DSG Capital Advisors LLC Raises Stock Holdings in McKesson Corporation $MCK

DSG Capital Advisors LLC lifted its holdings in shares of McKesson Corporation (NYSE:MCK) by 97.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,570 shares of the company’s stock after acquiring an additional 776 shares during the period. DSG Capital Advisors LLC’s holdings in McKesson were worth $1,213,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of MCK. Barlow Wealth Partners Inc. acquired a new position in McKesson in the third quarter valued at $12,640,000. Paragon Private Wealth Management LLC boosted its stake in shares of McKesson by 8.0% during the third quarter. Paragon Private Wealth Management LLC now owns 618 shares of the company’s stock worth $478,000 after buying an additional 46 shares during the period. Northstar Advisory Group LLC purchased a new position in shares of McKesson during the third quarter worth about $1,226,000. James Investment Research Inc. acquired a new position in McKesson in the 3rd quarter valued at about $533,000. Finally, AEGON ASSET MANAGEMENT UK Plc raised its stake in McKesson by 36.1% during the 3rd quarter. AEGON ASSET MANAGEMENT UK Plc now owns 859 shares of the company’s stock valued at $664,000 after acquiring an additional 228 shares during the last quarter. Hedge funds and other institutional investors own 85.07% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have weighed in on the company. TD Cowen reiterated a “buy” rating on shares of McKesson in a research note on Monday, December 22nd. Zacks Research lowered shares of McKesson from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 25th. Evercore ISI reissued an “outperform” rating and issued a $1,000.00 price objective on shares of McKesson in a research note on Thursday, November 6th. Wall Street Zen cut shares of McKesson from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of McKesson in a report on Wednesday, December 10th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $895.79.

Insider Activity at McKesson

In related news, CAO Napoleon B. Rutledge, Jr. sold 329 shares of the company’s stock in a transaction that occurred on Friday, November 7th. The stock was sold at an average price of $861.63, for a total value of $283,476.27. Following the sale, the chief accounting officer owned 328 shares in the company, valued at $282,614.64. This represents a 50.08% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Thomas L. Rodgers sold 276 shares of McKesson stock in a transaction on Monday, January 5th. The stock was sold at an average price of $816.18, for a total value of $225,265.68. Following the transaction, the executive vice president directly owned 2,268 shares of the company’s stock, valued at approximately $1,851,096.24. This represents a 10.85% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.08% of the stock is owned by insiders.

McKesson Stock Performance

McKesson stock opened at $835.21 on Wednesday. The company has a market cap of $103.09 billion, a P/E ratio of 25.99, a price-to-earnings-growth ratio of 1.36 and a beta of 0.41. McKesson Corporation has a one year low of $570.51 and a one year high of $895.58. The business has a fifty day moving average of $829.92 and a two-hundred day moving average of $772.05.

McKesson (NYSE:MCK) last announced its quarterly earnings results on Wednesday, November 5th. The company reported $9.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $8.84 by $1.02. McKesson had a net margin of 1.04% and a negative return on equity of 248.14%. The business had revenue of $103.15 billion during the quarter, compared to the consensus estimate of $103.80 billion. During the same quarter last year, the firm posted $7.07 EPS. The business’s revenue was up 10.2% compared to the same quarter last year. Sell-side analysts predict that McKesson Corporation will post 32.77 EPS for the current year.

McKesson Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, January 2nd. Stockholders of record on Monday, December 1st were given a dividend of $0.82 per share. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date was Monday, December 1st. McKesson’s dividend payout ratio (DPR) is presently 10.21%.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.